|
||||||||||||||
|
|
Breast Cancer Treatments: An Integrative Approach In this twenty first century, the word cancer still strikes terror in the hearts of most people particularly those who have seen a loved one suffer from it. Cancer in its various forms is the second leading cause of death after heart disease. Breast cancer has become the second largest cause of cancer death in women, after lung cancer, and the leading cause of death for women between the ages of 35 and 54. Almost 20,000 Canadians will contract breast cancer this year and over 5,000 will die from this disease. In fact, Canada has the second highest incidence of breast cancer in the world (trailing only the United States). What we do know is that the pieces to the breast cancer puzzle will only be uncovered through further research. While the incidence of breast cancer as well as the recovery rate continues to rise, breast cancer is hardly a new affliction. Breast cancer has been around for centuries and the Breast Cancer Society of Canada believes we are closer to a cure than ever before. Conventional treatments, however, have been of limited success in presenting a cure for breast cancer especially in advanced stages. Most have a very high incidence of serious side effects. Doctors feel their hands tied up to recommend any further treatment especially after the failure of an initial protocol of chemotherapy or radiation. Patients are sent home or to palliative care. Promising genetic and immune therapies are emerging and promising to provide more tools in our fight against breast cancer. Most conventional practitioners ignore a large number of available complementary therapies that are being employed to treat cancer patients, improve their diet, detoxify their systems, stimulate their immune system, and provide the essential nutrients for their cells that are affected by the conventional toxic treatments. The medical community of the world, both conventional and alternative, has a moral obligation to unite in their fight against cancer. An integrative composite system employing therapeutic modalities from all medical disciplines would be the best tool for improving patients chances for survival. The following are several researched alternative cancer treatment modalities employed by different health professionals all over the globe: Poly MVA This compound is a non-toxic Lipoic acid / Palladium complex. Lipoic acid is a natural powerful antioxidant that is both water and fat soluble, which permits the Poly-MVA to pass across the cell membranes and the blood brain barrier, which is impossible for most drugs, including chemotherapy. When Poly enters cancer cells, protein radicals are formed which denature the tumor cells proteins. Since normal cells are capable of converting the radicals into energy and water, no harm can occur. The most dramatic responses were noted with brain tumors. Other tumors that respond well are breast, ovarian, prostate, colon, and lung cancer, among others. The original human trials were done in Canada by the late oncologist, Dr. Rudy Falk, usually in conjunction with standard chemotherapy for more than five years. He reported benefits including pain reduction or control, improved appetite and weight gain, and increasing energy. Some patients are still using low doses of Poly-MVA and have no signs of cancer after ten years of use.1 Hyaluronic Acid (HA) It is a naturally occurring substance and as part of the extra cellular matrix is present throughout all tissue and surrounding cells. Because of the altered status of the tumor, its anaerobic metabolism, and its abnormal vasculature, only a small portion of the tumor is affected by cytotoxic drugs. However, simply by mixing them physically with HA, they loosely combine and will target the sites where HA is deficient and across the blood brain barrier. Clinical studies showed that the use of HA as a carrier/targeting vehicle can enhance the effect of some, if not all, drugs such as NSAIDs, immunosuppressive agents, cytotoxic anticancer drug therapy and drugs for the relief of atheromatous blood vessel disease. 2 Investigations have moreover shown that tumors possess several HA receptors (CD44, RHAMM, etc.). This fact explains that HA will help cytotoxic drugs act specifically with the tumor cells, thus reducing their side effects on other normal cells. 3 Vitamin C A growing number of studies in vitro as well as in vivo suggest the use of high dose intravenous vitamin C as an adjunctive therapy for cancer patients. Several clinical experiences demonstrate the ability of vitamin C to arrest progress and shrink tumors. 4 Addition of magnesium and Vitamin B6 did inhibit oxalate stone formation in stone formers. Patients should also be screened for red blood cell G6PD deficiency to prevent hemolysis. 5 Adding different nutrients (Glutathione, Taurine, etc.) and trace elements will help enhance the nutritional state of the patient and thus maintain cellular metabolism at an optimal functional level. Oxygenation Therapy The most fundamental feature of a cancer cell is that it is relatively anaerobic. It needs sixty percent less oxygen than a normal healthy cell. It does very poorly in the presence of excess oxygen. All of this points toward the oxidative therapies as a decent treatment for cancer and a decent preventive measure as well. These include ozone, Hydrogen peroxide, and hyperbaric oxygen. The improvement in the immune system is also demonstrated by increased natural killer cell activity. In vitro studies have shown that cancer cultures treated with ozone along with 5-FU did not develop resistance to chemotherapy, as did the untreated colonies. This adjunctive therapy with chemotherapy and radiation therapy is further enhanced if ozone is used at the same time with Ultraviolet Blood Irradiation Therapy (UBIT). 6 Immunotherapy In order for cancer to occur, the immune system must have failed. So what went wrong? Extensive research has revealed that the dendritic cells are there in and around the tumor, but they are immature. There is also a change in the quantity or quality of the Natural Killer cells. Through the Tumor tissue specimen or urine collection, a comprehensive cancer vaccine could be prepared which is comprised of: Tumor-specific antigen injections Cytokine injections to stimulate dendritic cells maturation. Heat shock protein/tumor specific antigen injections that act as antigen chaperones to the dendritic cells. 7 Clinical responses were reported in greater than 40% in breast cancer patients of all stages, 63% in melanoma, and a 67% response in non-Hodgkins lymphoma patients. Other cancers including colorectal, lung, mesothelioma, ovarian, pancreatic, prostate, and thyroid have also shown significant clinical responses to the immunotherapy. 8 Other immune modulators include: Ney Tumorin: is a biomodular homeopathic German medication for the treatment of cancer. It activates the immune system on one hand and also influences directly the differentiation of the tumor cell. 9 Ney Thymun: a first line homeopathic choice in thymus therapy. Only on contact with thymus factors do precursor cells derived from the bone marrow develop into mature, immunologically competent cytotoxic T lymphocytes. Clinical studies have shown that Ney thymun increases the functional power of T lymphocytes, stimulates natural killer cells, produces an increase in autogenic interferons, and inhibits the growth of melanoma cells. 10 Natural Killer cells stimulants: these include MGN III, Immpower, NK Immune, IP 6, etc. Iscador: Mistletoe contains a cytotoxic lectin, viscumin which is both cytotoxic and immunostimulatory. It induces tumor necrosis, increases natural killer cell activity, increases production of interleukins 1 and 6; activates macrophages; induces programmed cell death (apoptosis), and protects DNA in normal cells during chemotherapy. A German study done by Dr. Ronald Grossarth-Maticek of the Institute for Preventive Medicine in Heidelberg shows that, when used as adjunctive treatment in patients with a variety of cancers, it can increase survival time by as much as 40%. Research indicates that mistletoe extract is most effective when used in conjunction with conventional medical care for the treatment of solid tumors such as breast cancer. Wob-Mugos and Wobenzyme: is a formula containing several kinds of hydrolytic, proteolytic enzymes from plant and animal sources that attack cancer in several ways. First, it attacks the coating on tumor cells, which disguise them from recognition by the immune system to, that the antigens are exposed. Second, it stimulates various components of the immune system such as Natural Killer cells, T-cells and Tumor Necrosis factor. Third, it removes the "sticky" coating on cancer cells that allow them to adhere to other parts of the body, in effect, lessening the chances of metastasis. Detoxification: Removal of toxins from the body is considered as a very important part of the treatment. A variety of approaches are used, including colon cleansing, fasting, chelation, water therapy, heat therapy, and nutritional, herbal, and homeopathic methods. Max Gerson introduced coffee into the enema procedure, which causes the liver to release stored up toxins into the digestive system to be eliminated. Increasing your water intake may be one of the best ways to get rid of toxins in the body. Finally, we can discuss exciting complimentary treatment further, but this was meant to be just a summary of some of the more important integrative approaches employed in cancer therapy. For more detailed information you can log on or call (647)293-5363 or (705)735-2354. 1- Poly-MVA, Cancer Breakthrough, Al Sanchez. AMARC: Chula Vista, California 91910. 2- 1st International Workshop on Hyaluronan in Drug Delivery. Windsor, UK 1992. 3- 4th International Workshop on Hyaluronan in Drug Delivery. Gressy, France, 1996. 4-Clinical & Experimental experiences with Intravenous Vitamin C. Bio- Communications research institute, Wichita, Kansas, 67219. 5-RECNAC, Protocol for the use of High Dose Intravenous Ascorbate as a Cytotoxic Chemotherapeutic agent. Wichita, Kansas, 67219. 6-The Principles and Applications of Ozone Therapy, by F. Shallenberger, MD. 1999. 7-Tomorrows cancer vaccine today. Neil H. Riordan, 1999. 8- Autologous Immunotherapy of Cancer. J. L. McCoy, Ph.D. Stockbridge, GA 30281. 9- Treatment Schedule Proposal with NeyTumorin. Vitorgan, Ostfildren, Germany. 10- Ney Thymun, a first choice in Thymus-therapy. Vitorgan, Ostfildren, Germany. |
|
||||||||||||
|
||||||||||||||